Savara SVRA
NASDAQ SVRA
$4.66 -0.01 (-0.32%)
As of: Oct 22, 2026 · 10:44 AM EDT

Savara (SVRA) EBT Margin (2015 - 2026)

Updated

Savara (SVRA) reported EBT Margin of -1301200.00% for Q4 2020, down 1296987.11 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBT Margin (2015 - 2026) Analysis & Trends

For FY2020, Savara posted EBT Margin of -19182.88%.

  • EBT Margin has a five-year change of -2518.06 percentage points (FY2015 to FY2020).
  • By year, EBT Margin came in at -2820.00% in FY2016 (+13844.81 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,166.12 Bn 1,134.70 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 634.67 Bn 553.20 Bn 17.26 Bn 26.66%
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn 25.18%
4 Merck 377.66 Bn 332.04 Bn 12.21 Bn -4.11%
5 Novartis Ag 303.82 Bn 267.81 Bn 11.24 Bn 29.63%
6 Astrazeneca 266.80 Bn 240.49 Bn 12.86 Bn 18.19%
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn -131.41%
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn -4.34%
10 Savara 1.18 Bn 440.62 Mn - -4,941.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,941.50%
Mar 31, 2026 -3,688.74%
Dec 31, 2025 -2,796.57%
Sep 30, 2025 -5,520.99%
Jun 30, 2025 -3,413.68%
Mar 31, 2025 -1,778.30%
Dec 31, 2024 -1,629.59%
Sep 30, 2024 -1,238.00%
Dec 31, 2023 -1,160.63%
Dec 31, 2022 -1,771.17%
Dec 31, 2020 -1,301,200.00%
Sep 30, 2020 -4,212.89%
Sep 30, 2019 -248,060.00%
Jun 30, 2019 -70,770.97%
Dec 31, 2018 -11,124.79%
Sep 30, 2018 -11,315.32%
Mar 31, 2017 -5,543.62%
Dec 31, 2016 -1,081.25%
Sep 30, 2016 -7,171.11%
Dec 31, 2015 -22,520.37%
API Access

Savara EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY